Skin thickness progression rate: a predictor of mortality and early internal organ involvement in diffuse scleroderma

被引:141
作者
Domsic, Robyn T. [1 ]
Rodriguez-Reyna, Tatiana [2 ]
Lucas, Mary [1 ]
Fertig, Noreen [1 ]
Medsger, Thomas A., Jr. [1 ]
机构
[1] Univ Pittsburgh, Sch Med, Dept Med, Div Rheumatol, Pittsburgh, PA USA
[2] Natl Inst Med Sci & Nutr Salvador Zubiran, Mexico City, DF, Mexico
关键词
SYSTEMIC-SCLEROSIS SCLERODERMA; SURVIVAL; FEATURES; DISEASE; DEATH; EMPHASIS; ANTIBODY; COHORT; SCORE;
D O I
10.1136/ard.2009.127621
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective To examine the association of skin thickness progression rate (STPR) with mortality, and as a predictor of future internal organ involvement in an inception cohort of diffuse cutaneous systemic sclerosis (SSc) patients. Methods Diffuse cutaneous SSc patients older than 16 years of age evaluated at the University of Pittsburgh within 2 years of the first evidence of skin thickening between 1980 and 2005 were eligible. The authors calculated the STPR on these patients, and examined the relationship of this variable to the development of early internal organ involvement and short-term mortality using logistic regression. Results 826 patients were included in the analysis. Patients with a rapid STPR experienced significantly reduced short-term survival at 1 and 2 years from the time of first Pittsburgh evaluation (p=0.002). Patients with a rapid STPR were more likely to develop renal crisis within 1-2 years of follow-up. Rapid STPR was found to be an independent predictor of both mortality (OR 1.72; 95% CI 1.13 to 2.62; p=0.01) and 'renal crisis' (OR 2.05, 95% CI 1.10 to 3.85; p=0.02) within 2 years from first evaluation. Conclusion The STPR is an easy measure to perform at the time of initial evaluation for identifying those diffuse cutaneous SSc patients who are at increased risk of mortality and the development of renal crisis during the following 2 years.
引用
收藏
页码:104 / 109
页数:6
相关论文
共 30 条
  • [1] PREDICTORS OF SURVIVAL IN SYSTEMIC-SCLEROSIS (SCLERODERMA)
    ALTMAN, RD
    MEDSGER, TA
    BLOCH, DA
    MICHEL, BA
    [J]. ARTHRITIS AND RHEUMATISM, 1991, 34 (04): : 403 - 413
  • [2] BARNETT AJ, 1988, J RHEUMATOL, V15, P276
  • [3] SURVIVAL IN SCLERODERMA
    BENNETT, R
    BLUESTONE, R
    HOLT, PJL
    BYWATERS, EG
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 1971, 30 (06) : 581 - +
  • [4] Bryan C, 1996, BRIT J RHEUMATOL, V35, P1122
  • [5] Clements PJ, 2000, ARTHRITIS RHEUM-US, V43, P2445, DOI 10.1002/1529-0131(200011)43:11<2445::AID-ANR11>3.0.CO
  • [6] 2-Q
  • [7] Survival and causes of death in 366 Hungarian patients with systemic sclerosis
    Czirjak, L.
    Kumanovics, G.
    Varju, C.
    Nagy, Z.
    Pakozdi, A.
    Szekanecz, Z.
    Szucs, G.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2008, 67 (01) : 59 - 63
  • [8] PROGRESSIVE SYSTEMIC-SCLEROSIS IN AUCKLAND - A 10 YEAR REVIEW WITH EMPHASIS ON PROGNOSTIC FEATURES
    EASON, RJ
    TAN, PL
    GOW, PJ
    [J]. AUSTRALIAN AND NEW ZEALAND JOURNAL OF MEDICINE, 1981, 11 (06): : 657 - 662
  • [9] PROGNOSTIC SIGNIFICANCE OF RAYNAUDS PHENOMENON AND OTHER CLINICAL CHARACTERISTICS OF SYSTEMIC SCLERODERMA - A STUDY OF 271 CASES
    FARMER, RG
    GIFFORD, RW
    HINES, EA
    [J]. CIRCULATION, 1960, 21 (06) : 1088 - 1095
  • [10] Systemic sclerosis: Demographic, clinical, and serologic features and survival in 1,012 Italian patients
    Ferri, C
    Valentini, G
    Cozzi, F
    Sebastiani, M
    Michelassi, C
    La Montagna, G
    Bullo, A
    Cazzato, M
    Tirri, E
    Storino, F
    Giuggioli, D
    Cuomo, G
    Rosada, M
    Bombardieri, S
    Todesco, S
    Tirri, G
    [J]. MEDICINE, 2002, 81 (02) : 139 - 153